TIAA CREF Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $450M | Buy |
|
|||||
|
2018
Q4 | $188M | Sell |
|
|||||
|
2018
Q3 | $334M | Sell |
|
|||||
|
2018
Q2 | $326M | Sell |
|
|||||
|
2018
Q1 | $391M | Sell |
|
|||||
|
2017
Q4 | $459M | Buy |
|
|||||
|
2017
Q3 | $480M | Buy |
|
|||||
|
2017
Q2 | $392M | Buy |
|
|||||
|
2017
Q1 | $275M | Sell |
|
|||||
|
2016
Q4 | $313M | Buy |
|
|||||
|
2016
Q3 | $303K | Sell |
|
|||||
|
2016
Q2 | $345M | Buy |
|
|||||
|
2016
Q1 | $305M | Sell |
|
|||||
|
2015
Q4 | $451M | Buy |
|
|||||
|
2015
Q3 | $321M | Sell |
|
|||||
|
2015
Q2 | $559M | Buy |
|
|||||
|
2015
Q1 | $409M | Sell |
|
|||||
|
2014
Q4 | $454M | Buy |
|
|||||
|
2014
Q3 | $338M | Buy |
|
|||||
|
2014
Q2 | $311M | Buy |
|
|||||
|
2014
Q1 | $267M | Sell |
|
|||||
|
2013
Q4 | $372M | Sell |
|
|||||
|
2013
Q3 | $370M | Buy |
|
|||||
|
2013
Q2 | $247M | Buy |
|